ArticleViruses2022

Effects of Casirivimab/Imdevimab Monoclonal Antibody Treatment among Vaccinated Patients Infected by SARS-CoV-2 Delta Variant.

Gaetano Cicchitto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.